118 related articles for article (PubMed ID: 21958855)
21. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET.
Jarkas N; Voll RJ; Williams L; Goodman MM
Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164
[TBL] [Abstract][Full Text] [Related]
22. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
[TBL] [Abstract][Full Text] [Related]
23. A dual fluorinated and iodinated radiotracer for PET and SPECT imaging of β-amyloid plaques in the brain.
Watanabe H; Ono M; Kimura H; Kagawa S; Nishii R; Fuchigami T; Haratake M; Nakayama M; Saji H
Bioorg Med Chem Lett; 2011 Nov; 21(21):6519-22. PubMed ID: 21920750
[TBL] [Abstract][Full Text] [Related]
24. The use of biopartitioning micellar chromatography and immobilized artificial membrane column for in silico and in vitro determination of blood-brain barrier penetration of phenols.
Stępnik KE; Malinowska I
J Chromatogr A; 2013 Apr; 1286():127-36. PubMed ID: 23506703
[TBL] [Abstract][Full Text] [Related]
25. PET radiotracers: crossing the blood-brain barrier and surviving metabolism.
Pike VW
Trends Pharmacol Sci; 2009 Aug; 30(8):431-40. PubMed ID: 19616318
[TBL] [Abstract][Full Text] [Related]
26. Quantitative micro-SPECT/CT for detecting focused ultrasound-induced blood-brain barrier opening in the rat.
Lin KJ; Liu HL; Hsu PH; Chung YH; Huang WC; Chen JC; Wey SP; Yen TC; Hsiao IT
Nucl Med Biol; 2009 Oct; 36(7):853-61. PubMed ID: 19720297
[TBL] [Abstract][Full Text] [Related]
27. New-generation radiotracers for nAChR and NET.
Ding YS; Fowler J
Nucl Med Biol; 2005 Oct; 32(7):707-18. PubMed ID: 16243646
[TBL] [Abstract][Full Text] [Related]
28. First in vivo evaluation of a potential SPECT brain radiotracer for the gonadotropin releasing hormone receptor.
Fjellaksel R; Oteiza A; Martin-Armas M; Riss PJ; Hjelstuen OK; Kuttner S; Hansen JH; Sundset R
BMC Res Notes; 2018 Nov; 11(1):811. PubMed ID: 30442192
[TBL] [Abstract][Full Text] [Related]
29. Binding of two potential imaging agents targeting amyloid plaques in postmortem brain tissues of patients with Alzheimer's disease.
Kung MP; Hou C; Zhuang ZP; Skovronsky D; Kung HF
Brain Res; 2004 Oct; 1025(1-2):98-105. PubMed ID: 15464749
[TBL] [Abstract][Full Text] [Related]
30. [11C]CURB: Evaluation of a novel radiotracer for imaging fatty acid amide hydrolase by positron emission tomography.
Wilson AA; Garcia A; Parkes J; Houle S; Tong J; Vasdev N
Nucl Med Biol; 2011 Feb; 38(2):247-53. PubMed ID: 21315280
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of potent and selective human V1a receptor antagonists as potential ligands for PET or SPECT imaging.
Fabio K; Guillon C; Lacey CJ; Lu SF; Heindel ND; Ferris CF; Placzek M; Jones G; Brownstein MJ; Simon NG
Bioorg Med Chem; 2012 Feb; 20(3):1337-45. PubMed ID: 22249122
[TBL] [Abstract][Full Text] [Related]
33. Evaluation in rats and primates of [11C]-mecamylamine, a potential nicotinic acetylcholine receptor radioligand for positron emission tomography.
Sobrio F; Debruyne D; Dhilly M; Chazalviel L; Camsonne R; Kakiuchi T; Tsukada H; Barré L
Neurochem Int; 2005 May; 46(6):479-88. PubMed ID: 15769550
[TBL] [Abstract][Full Text] [Related]
34. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
[TBL] [Abstract][Full Text] [Related]
35. Identifying novel radiotracers for PET imaging of the brain: application of LC-MS/MS to tracer identification.
Barth V; Need A
ACS Chem Neurosci; 2014 Dec; 5(12):1148-53. PubMed ID: 24828747
[TBL] [Abstract][Full Text] [Related]
36. Label-free assay for the assessment of nonspecific binding of positron emission tomography tracer candidates.
Assmus F; Seelig A; Gobbi L; Borroni E; Glaentzlin P; Fischer H
Eur J Pharm Sci; 2015 Nov; 79():27-35. PubMed ID: 26341407
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of (R)-[11C]verapamil as PET tracer of P-glycoprotein function in the blood-brain barrier: kinetics and metabolism in the rat.
Luurtsema G; Molthoff CF; Schuit RC; Windhorst AD; Lammertsma AA; Franssen EJ
Nucl Med Biol; 2005 Jan; 32(1):87-93. PubMed ID: 15691665
[TBL] [Abstract][Full Text] [Related]
38. BZM055, an iodinated radiotracer candidate for PET and SPECT imaging of myelin and FTY720 brain distribution.
Briard E; Orain D; Beerli C; Billich A; Streiff M; Bigaud M; Auberson YP
ChemMedChem; 2011 Apr; 6(4):667-77. PubMed ID: 21280229
[TBL] [Abstract][Full Text] [Related]
39. Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier.
Reichel A; Begley DJ
Pharm Res; 1998 Aug; 15(8):1270-4. PubMed ID: 9706060
[TBL] [Abstract][Full Text] [Related]
40. Comparative evaluation of positron emission tomography radiotracers for imaging the norepinephrine transporter: (S,S) and (R,R) enantiomers of reboxetine analogs ([11C]methylreboxetine, 3-Cl-[11C]methylreboxetine and [18F]fluororeboxetine), (R)-[11C]nisoxetine, [11C]oxaprotiline and [11C]lortalamine.
Ding YS; Lin KS; Logan J; Benveniste H; Carter P
J Neurochem; 2005 Jul; 94(2):337-51. PubMed ID: 15998285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
